The Pharmacy Times® Classical Hematology Resource Center is a comprehensive resource for clinical news and expert insights on the treatment of non-cancerous blood disorders, including thrombocytopenia, hemophilia A and B, sickle cell disease, anemia, and more.
May 19th 2025
The approval expands the therapy’s indication to children as young as 7 years.
Rilzabrutinib Granted Orphan Drug Designation For Multiple Rare, Immune-Mediated Conditions
April 4th 2025The new designations span both warm autoimmune hemolytic anemia and IgG4-related disease, 2 rare, immune-mediated conditions that burden patients due to a lack of available treatment options.
Read More
Moderate Aerobic Exercise Improves Hematological Parameters in Sedentary Young Adults
March 26th 2025In previously sedentary young males and females, 14 days of moderate aerobic exercise increased red and white blood cell counts and hemoglobin concentrations without altering key cardiometabolic enzymes.
Read More
Early Intervention With IV Iron Is Safe, Effective for Anemia During Pregnancy
March 12th 2025Compared with daily oral iron, a single intravenous (IV) infusion of iron was shown to lower rates of low birth weight in infants and decrease reliance on further iron supplementation or transfusions in pregnant patients with anemia.
Read More
Weekly Mim8 Effective in Pediatric Hemophilia A With and Without Inhibitors
February 21st 2025The new data demonstrates the effectiveness of Mim8 in children with hemophilia A regardless of inhibitor status, expanding the populations in which the novel drug in development could have a treatment benefit.
Read More
FDA Grants Fast Track Designation to VAD044 for Treatment of Adults With HHT
November 19th 2024Clinical trial analysis results studying VAD-44 in patients with hereditary hemorrhagic telangiectasia (HTT) will be presented at the 2024 American Society of Hematology Annual Meeting & Exposition.
Read More